Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes.
Babak Benjamin NaviCenai ZhangCarla P ShermanRichard GenovaNatalie M LeMossHooman KamelScott T TagawaAshish SaxenaAllyson J OceanScott E KasnerAndrea N EdgintonMitchell S V ElkindEllinor PeerschkeLisa M DeAngelisPublished in: Journal of thrombosis and haemostasis : JTH (2022)
Markers of hypercoagulability and embolic disease may be associated with adverse clinical outcomes in cancer-related stroke.